NovoBind Livestock Therapeutics Inc.
PrivateLast Round
Grant
Nov 1, 2021
Total Funding Raised
$1.08M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NovoBind Livestock Therapeutics Inc. is a biotechnology company that develops next-generation biologics to neutralize bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoBind Livestock Therapeutics Inc. Comparables
Compare NovoBind Livestock Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Folium Science | 83% | |
| BiomEdit | 79% | |
| Animab | 73% |
NovoBind Livestock Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
| Series A | Feb 19, 2020 | ||||
| Grant | Jul 1, 2019 |
Key People
Founding team and executive leadership
NovoBind Livestock Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agriculture and Agri-Food Canada | Grant |
| Canada-BC Agri-Innovation Program | Grant |
| National Research Council of Canada | Grant |
| Natural Products Canada | Series A |
| Mindset Venture Group | Series A |
| VANTEC Angel Network | Seed |
| Seventure Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 449% MoM, reaching 2.4K.
- Nov 1, 2021
$486K grant received from Agriculture and Agri-Food Canada.
NovoBind Livestock Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NovoBind Livestock Therapeutics Inc.'s valuation, stock price, and market status.
Is NovoBind Livestock Therapeutics Inc. a public or private company?
NovoBind Livestock Therapeutics Inc. is a private company.
What is the current stock price of NovoBind Livestock Therapeutics Inc.?
NovoBind Livestock Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is NovoBind Livestock Therapeutics Inc. worth (valuation)?
Valuation information for NovoBind Livestock Therapeutics Inc. is not publicly available.
Can I buy NovoBind Livestock Therapeutics Inc. stock?
NovoBind Livestock Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NovoBind Livestock Therapeutics Inc.'s last funding round?
NovoBind Livestock Therapeutics Inc.'s most recent funding round was Grant on November 1, 2021.
Who are the main investors in NovoBind Livestock Therapeutics Inc.?
Key investors in NovoBind Livestock Therapeutics Inc. include Agriculture and Agri-Food Canada, Canada-BC Agri-Innovation Program, National Research Council of Canada, Natural Products Canada, Mindset Venture Group.
Will NovoBind Livestock Therapeutics Inc. IPO soon?
No public IPO plans have been announced for NovoBind Livestock Therapeutics Inc..
How can I track NovoBind Livestock Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NovoBind Livestock Therapeutics Inc.'s secondary market activity and sign up for updates.